Jefferies Group's NVO Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 16,524 shares of Novo Nordisk A/S (NVO) worth $607,257, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in NVO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 14,412 shares. Largest reduction occurred in Q2 2025, reducing 7,664 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +14,412 | Add 682.39% | 16,524 | $36.75 |
| Q4 2025 | -3,319 | Reduce 61.11% | 2,112 | $50.89 |
| Q3 2025 | +3,012 | Add 124.51% | 5,431 | $55.49 |
| Q2 2025 | -7,664 | Reduce 76.01% | 2,419 | $69.02 |
| Q1 2025 | -4,836 | Reduce 32.42% | 10,083 | $69.44 |
| Q4 2024 | -4,315 | Reduce 22.43% | 14,919 | $86.02 |
| Q3 2024 | +11,329 | Add 143.31% | 19,234 | $119.07 |
| Q2 2024 | -4,334 | Reduce 35.41% | 7,905 | $142.74 |
| Q1 2024 | +4,580 | Add 59.80% | 12,239 | $128.40 |
| Q4 2023 | -7,208 | Reduce 48.48% | 7,659 | $103.45 |
| Q3 2023 | +9,383 | Add 171.10% | 14,867 | $90.94 |
| Q2 2023 | -2,120 | Reduce 27.88% | 5,484 | $80.92 |
| Q1 2023 | -2,950 | Reduce 27.95% | 7,604 | $79.57 |
| Q4 2022 | +10,554 | New Buy | 10,554 | $67.67 |
Jefferies Group's Novo Nordisk A/S Investment FAQs
Jefferies Group first purchased Novo Nordisk A/S (NVO) in Q4 2022, acquiring 10,554 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Novo Nordisk A/S (NVO) for 14 quarters since Q4 2022.
Jefferies Group's largest addition to Novo Nordisk A/S (NVO) was in Q1 2026, adding 16,524 shares worth $607,257.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 16,524 shares of Novo Nordisk A/S (NVO), valued at approximately $607,257.
As of the Q1 2026 filing, Novo Nordisk A/S (NVO) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Novo Nordisk A/S (NVO) was 19,234 shares, as reported at the end of Q3 2024.